![]() ![]() |
Codon DevicesCodon Devices is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices' proprietary synthesis and design technologies improve the productivity, throughput and flexibility of its industrial, pharmaceutical and academic customers in a paradigm shift to what the company calls Constructive Biology™. The company's focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy. Codon Devices' BioFAB™ platform uses sophisticated informatics, robotics and sequencing technologies to accurately synthesize genetic codes orders of magnitude more rapidly and cost-effectively than other currently available technology. Codon Devices is currently scaling the platform to design and construct engineered genetic devices hundreds of kilobases to megabases in length. Recent NewsCodon Devices and Merrimack Pharmaceuticals Enter Into Research, Development and License AgreementCodon Devices Secures $11 Million in Series B FinancingCodon Devices Awarded $1.5 Million Grant by National Institute of Standards and TechnologyCodon Devices Announces Appointment of Brian M. Baynes as PresidentCodon Devices Expands Gene Scaffolding ReachCodon Devices Opens European HeadquartersCodon Devices and Agrivida Enter into Development Agreement for Biofuel Applications |
![]() CEOBrian M. Baynes, Ph.D.Contact InfoOne Kendall SquareBuilding 300 Cambridge, Massachusetts 02139 Phone: 617.995.7999 Fax: 617.995.7970 Key LinksWebsiteJobs Info Highland Team Bob Higgins
Graham Gardner, M.D.
|